What Happened?
Shares of behavioral health company Acadia Healthcare (NASDAQ:ACHC) fell 9% in the afternoon session after the company released a disappointing financial forecast for its upcoming second quarter that fell short of analyst expectations, overshadowing its first-quarter results.
The operator of behavioral healthcare facilities projected second-quarter revenue of approximately $842.5 million at the midpoint, which came in 2.7% below analysts’ estimates. Furthermore, its adjusted earnings per share guidance for the quarter also missed Wall Street’s expectations. While Acadia’s first-quarter revenue grew 7.6% year-on-year to $828.8 million and its adjusted earnings per share of $0.37 beat estimates, these results were not enough to outweigh the weak outlook. The company’s adjusted earnings per share for the first quarter were down from $0.40 in the same period last year.
The shares closed the day at $25.91, down 8.3% from previous close.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Acadia Healthcare? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Acadia Healthcare’s shares are extremely volatile and have had 33 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 3 months ago when the stock gained 24% on the news that the company announced the departure of Christopher H. Hunter and immediately reappointed former CEO Debra K. Osteen to lead.
Osteen previously served as Acadia’s CEO from December 2018 to March 2022. During that time, she was credited with turning the business around, which led to a near 100% increase in the stock’s price. The market’s strong positive reaction suggested investors were optimistic about her return. Analysts noted her successful track record as a reason for investor confidence. Adding to the news, Acadia reaffirmed its full-year 2025 financial guidance, which indicated stability in the company’s underlying business outlook despite the leadership change.
Acadia Healthcare is up 81.3% since the beginning of the year, and at $25.91 per share, it is trading close to its 52-week high of $28.26 from April 2026. Despite the year-to-date gain, investors who bought $1,000 worth of Acadia Healthcare’s shares 5 years ago would now be looking at only $425.23.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.